UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

The FASEB journal, 2005-11, Vol.19 (13), p.1842-1844

2005

Volltextzugriff (PDF)

SOST/sclerostin, an osteocyte-derived negative regulator of bone formation

Cytokine & growth factor reviews, 2005-06, Vol.16 (3), p.319-327

2005

Volltextzugriff (PDF)

Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways

The Journal of biological chemistry, 2010-12, Vol.285 (53), p.41614-41626

2010

Volltextzugriff (PDF)

Osteocyte-Derived Sclerostin Inhibits Bone Formation: Its Role in Bone Morphogenetic Protein and Wnt Signaling

Journal of bone and joint surgery. American volume, 2008-02, Vol.90 (Supplement_1), p.31-35

2008

Volltextzugriff (PDF)

Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A

Endocrinology (Philadelphia), 2002-04, Vol.143 (4), p.1545-1553

2002

Volltextzugriff (PDF)

Bone Mineral Density in Sclerosteosis; Affected Individuals and Gene Carriers

The journal of clinical endocrinology and metabolism, 2005-12, Vol.90 (12), p.6392-6395

2005

Volltextzugriff (PDF)

Downregulation of Wnt Signaling by Increased Expression of Dickkopf‐1 and ‐2 is a Prerequisite for Late‐Stage Osteoblast Differentiation of KS483 Cells

Journal of bone and mineral research, 2005-10, Vol.20 (10), p.1867-1877

2005

Volltextzugriff (PDF)

Lack of Noggin Expression by Cancer Cells Is a Determinant of the Osteoblast Response in Bone Metastases

The American journal of pathology, 2007, Vol.170 (1), p.160-175

2007

Volltextzugriff (PDF)

BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis

Journal of cell science, 2007-03, Vol.120 (6), p.964-972

2007

Volltextzugriff (PDF)

Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover

Journal of bone and mineral research, 2011-12, Vol.26 (12), p.2804-2811

2011

Volltextzugriff (PDF)

Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist

The Journal of experimental medicine, 2004-03, Vol.199 (6), p.805-814

2004

Volltextzugriff (PDF)

Effect of ultraviolet light on mood, depressive disorders and well‐being

Photodermatology, photoimmunology & photomedicine, 2018-09, Vol.34 (5), p.288-297

2018

Volltextzugriff (PDF)

Wnt but Not BMP Signaling Is Involved in the Inhibitory Action of Sclerostin on BMP‐Stimulated Bone Formation

Journal of bone and mineral research, 2007-01, Vol.22 (1), p.19-28

2007

Volltextzugriff (PDF)

Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling

Journal of bone and joint surgery. American volume, 2008-02, Vol.90 Suppl 1, p.31

2008

Volltextzugriff (PDF)

Osteocyte recruitment declines as the osteon fills in: Interacting effects of osteocytic sclerostin and previous hip fracture on the size of cortical canals in the femoral neck

Bone (New York, N.Y.), 2012-05, Vol.50 (5), p.1107-1114

2012

Volltextzugriff (PDF)

SOST expression is restricted to the great arteries during embryonic and neonatal cardiovascular development

Developmental dynamics, 2007-02, Vol.236 (2), p.606-612

2007

Volltextzugriff (PDF)

Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential

Haematologica (Roma), 2003-08, Vol.88 (8), p.845

2003

Volltextzugriff (PDF)

Mesenchymal stem cells promote engraftment of human umbilical cord blood–derived CD34 + cells in NOD/SCID mice

Experimental hematology, 2002-08, Vol.30 (8), p.870-878

2002

Volltextzugriff (PDF)

A new paradigm in the treatment of osteoporosis: Wnt pathway proteins and their antagonists

Current opinion in investigational drugs (London, England : 2000), 2007-04, Vol.8 (4), p.293

2007

Volltextzugriff (PDF)

Interleukin‐17: A New Bone Acting Cytokine In Vitro

Journal of bone and mineral research, 1999-09, Vol.14 (9), p.1513-1521

1999

Volltextzugriff (PDF)

Oestrogenic Compounds Modulate Cytokine-induced Nitric Oxide Production in Mouse Osteoblast-like Cells

Journal of pharmacy and pharmacology, 1999-12, Vol.51 (12), p.1409-1414

1999

Volltextzugriff (PDF)

274: Lack of Expression of Noggin and DICKKOPF-1 (DKK-1) by Prostate Cancer Cells Determines the Osteoblast Response in Bone Metastasis

The Journal of urology, 2007-04, Vol.177 (4), p.92-92

2007

Volltextzugriff (PDF)

IL‐1α, IL‐1β, IL‐6, and TNF‐α Steady‐State mRNA Levels Analyzed by Reverse Transcription‐Competitive PCR in Bone Marrow of Gonadectomized Mice

Journal of bone and mineral research, 1998-02, Vol.13 (2), p.185-194

1998

Volltextzugriff (PDF)

Prognostic markers for survival in patients with metastatic renal cell carcinoma treated with interleukin-2

Cancer Immunology, Immunotherapy, 1996-12, Vol.43 (5), p.293-298

1996

Volltextzugriff (PDF)

Aging effects on hepatic NADPH cytochrome P450 reductase, CYP2B1 & 2, and polymeric immunoglobulin receptor mRNAs in male fischer 344 rats

Experimental gerontology, 1994-03, Vol.29 (2), p.187-195

1994

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(28)
Buchkapitel
(1)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

SOST/sclerostin, an osteocyte-derived negative regulator of bone formation

Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways

Osteocyte-Derived Sclerostin Inhibits Bone Formation: Its Role in Bone Morphogenetic Protein and Wnt Signaling

Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A

Bone Mineral Density in Sclerosteosis; Affected Individuals and Gene Carriers

Downregulation of Wnt Signaling by Increased Expression of Dickkopf‐1 and ‐2 is a Prerequisite for Late‐Stage Osteoblast Differentiation of KS483 Cells

Lack of Noggin Expression by Cancer Cells Is a Determinant of the Osteoblast Response in Bone Metastases

BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis

Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover

Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist

Effect of ultraviolet light on mood, depressive disorders and well‐being

Wnt but Not BMP Signaling Is Involved in the Inhibitory Action of Sclerostin on BMP‐Stimulated Bone Formation

Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling

Osteocyte recruitment declines as the osteon fills in: Interacting effects of osteocytic sclerostin and previous hip fracture on the size of cortical canals in the femoral neck

SOST expression is restricted to the great arteries during embryonic and neonatal cardiovascular development

Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential

Mesenchymal stem cells promote engraftment of human umbilical cord blood–derived CD34 + cells in NOD/SCID mice

A new paradigm in the treatment of osteoporosis: Wnt pathway proteins and their antagonists

Interleukin‐17: A New Bone Acting Cytokine In Vitro

Oestrogenic Compounds Modulate Cytokine-induced Nitric Oxide Production in Mouse Osteoblast-like Cells

274: Lack of Expression of Noggin and DICKKOPF-1 (DKK-1) by Prostate Cancer Cells Determines the Osteoblast Response in Bone Metastasis

IL‐1α, IL‐1β, IL‐6, and TNF‐α Steady‐State mRNA Levels Analyzed by Reverse Transcription‐Competitive PCR in Bone Marrow of Gonadectomized Mice

Prognostic markers for survival in patients with metastatic renal cell carcinoma treated with interleukin-2

Aging effects on hepatic NADPH cytochrome P450 reductase, CYP2B1 & 2, and polymeric immunoglobulin receptor mRNAs in male fischer 344 rats

Suchergebnisse filtern